Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03539783 · ClinicalTrials.gov registry record

Identifying PARDS Endotypes

A clinical trial of Respiratory Distress Syndrome and Respiratory Distress Syndrome, Adult, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
76
Enrollment target
2
Study locations

NCT03539783: Completed study of Respiratory Distress Syndrome and Respiratory Distress Syndrome, Adult, sponsored by Children's Hospital Medical Center, Cincinnati.

NCT03539783 is a study of Respiratory Distress Syndrome and Respiratory Distress Syndrome, Adult that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 76 participants, below the 225-participant average among 8 other Respiratory Distress Syndrome trials with a reported enrollment target (66% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03539783, a study of Respiratory Distress Syndrome and Respiratory Distress Syndrome, Adult, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
76 participants
Enrollment target
2
Study locations

Study Summary

Pediatric acute respiratory distress syndrome (PARDS) is a severe and diffuse lung injury that is a common cause of admission and mortality in the pediatric intensive care unit (PICU). PARDS can be secondary to many different causes, and there are few therapies that have been shown beneficial in PARDS. This study seeks to identify important PARDS subtypes using gene expression profiling of bronchial epithelial cells from control and PARDS subjects.

Primary Outcome

Use of unbiased cluster analysis of gene expression to identify subtypes in PARDS

Interventions

  • DIAGNOSTIC_TEST Respiratory epithelial cell brushing

Study Locations (2)

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2018-04-01
Est. Completion 2022-09-05

What the finished NCT03539783 record still lists

NCT03539783 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 225-participant average among 8 other Respiratory Distress Syndrome trials with a reported enrollment target (66% lower).

The record links to 2 conditions, with Respiratory Distress Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Respiratory epithelial cell brushing is the first listed.

NCT03539783 reports a single indexed study location in Ohio, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03539783 about?

NCT03539783 is a clinical study titled "Identifying PARDS Endotypes". Pediatric acute respiratory distress syndrome (PARDS) is a severe and diffuse lung injury that is a common cause of admission and mortality in the pediatric intensive care unit (PICU). PARDS can be secondary to many different causes, and there are few therapies that have been shown beneficial in PAR...

What is the current status of trial NCT03539783?

This trial is currently completed. The enrollment target is 76 participants. The study started on 2018-04-01. Estimated completion is 2022-09-05.

What conditions does trial NCT03539783 study?

This clinical trial studies the following conditions: Respiratory Distress Syndrome, Respiratory Distress Syndrome, Adult.

What interventions are being tested in trial NCT03539783?

The interventions under investigation include: Respiratory epithelial cell brushing (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03539783?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03539783 being conducted?

This trial has 2 study locations across Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Respiratory Distress Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03539783's enrollment target sits among peer trials

76 6th of 8 higher than 3 of 8 other Respiratory Distress Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Respiratory Distress Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02615184 · 76 participants · Phase 2

    A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

  • NCT02821741 · 76 participants · NA

    Effects of External Ear Stimulation on Pain Perception and Mood

  • NCT03019757 · 76 participants

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

  • NCT03353584 · 76 participants · NA

    Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03539783, the US trial registry maintained by the National Library of Medicine. NCT03539783 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.